GE HealthCare Technologies annual r&d spending
2021
2022
2023
2024
2025
GE HealthCare Technologies R&D Spending Growth & History (GEHC)
GE HealthCare Technologies's r&d spending was $1.26B for fiscal 2025.
View full GE HealthCare Technologies company overviewGE HealthCare Technologies annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.26B | −$51.0M | −3.89% |
| 2024 | 2024-12-31 | $1.31B | $106.0M | +8.80% |
| 2023 | 2023-12-31 | $1.21B | $179.0M | +17.45% |
| 2022 | 2022-12-31 | $1.03B | $210.0M | +25.74% |
| 2021 | 2021-12-31 | $816.0M | — | — |
GE HealthCare Technologies quarterly r&d spending
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $323.0M | $21.0M | +6.95% |
| Q1 2026 | 2026-03-31 | $345.0M | $1.0M | +0.29% |
| Q4 2025 | 2025-12-31 | $322.0M | −$22.0M | −6.40% |
| Q3 2025 | 2025-09-30 | $292.0M | −$24.0M | −7.59% |
| Q2 2025 | 2025-06-30 | $302.0M | −$25.0M | −7.65% |
| Q1 2025 | 2025-03-31 | $344.0M | $20.0M | +6.17% |
| Q4 2024 | 2024-12-31 | $344.0M | $29.0M | +9.21% |
| Q3 2024 | 2024-09-30 | $316.0M | −$6.0M | −1.86% |
| Q2 2024 | 2024-06-30 | $327.0M | $29.0M | +9.73% |
| Q1 2024 | 2024-03-31 | $324.0M | $54.0M | +20.00% |
| Q4 2023 | 2023-12-31 | $315.0M | $44.0M | +16.24% |
| Q3 2023 | 2023-09-30 | $322.0M | $62.0M | +23.85% |
| Q2 2023 | 2023-06-30 | $298.0M | $41.0M | +15.95% |
| Q1 2023 | 2023-03-31 | $270.0M | $32.0M | +13.45% |
| Q4 2022 | 2022-12-31 | $271.0M | — | — |
| Q3 2022 | 2022-09-30 | $260.0M | — | — |
| Q2 2022 | 2022-06-30 | $257.0M | — | — |
| Q1 2022 | 2022-03-31 | $238.0M | — | — |
GE HealthCare Technologies r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, GE HealthCare Technologies's r&d spending increased from $816.0M to $1.26B, a change of $444.0M. The latest reported quarter, Q2 2026, shows $323.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GE HealthCare Technologies source filings ↗